AbCellera Results Presentation Deck

Q1 2023 BUSINESS UPDATE COPYRIGHT © ABCELLERA M ART Q1 2023. BUSINESS UPDATE SUMMARY. BUILDING THE INDUSTRY'S ENGINE FOR ANTIBODY THERAPEUTICS IN $821M 177 101 P AbCellera 9 in total cash, cash equivalents & marketable securities cumulative programs under contract cumulative partnered programs started molecules in the clinic

View entire presentation